Advanced search
Publication Cover
OncoTargets and Therapy Volume 9, 2016 - Issue
Submit an article Journal homepage
39
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery

Yan Liu1 Department of Ultrasonography, Jilin University, Changchun, People’s Republic of China
,
Ye Feng2 Department of Gastrointestinal Disease, China–Japan Union Hospital, Jilin University, Changchun, People’s Republic of China
,
Yongjian Gao2 Department of Gastrointestinal Disease, China–Japan Union Hospital, Jilin University, Changchun, People’s Republic of China
&
Ruizhi Hou2 Department of Gastrointestinal Disease, China–Japan Union Hospital, Jilin University, Changchun, People’s Republic of ChinaCorrespondence[email protected]
Pages 1269-1273 | Published online: 07 Mar 2016

References

  • TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • BrayFFerlayJLaversanneMCancer incidence in five continents: inclusion criteria, highlights from volume X and the global status of cancer registrationInt J Cancer201513792060207126135522
  • McLeanMHEl-OmarEMGenetics of gastric cancerNat Rev Gastroenterol Hepatol2014111166467425134511
  • D’AngelicaMGonenMBrennanMFTurnbullADBainsMKarpehMSPatterns of initial recurrence in completely resected gastric adenocarcinomaAnn Surg2004240580881615492562
  • YooCHNohSHShinDWChoiSHMinJSRecurrence following curative resection for gastric carcinomaBr J Surg200087223624210671934
  • ChanMMSjoquistKMZalcbergJRClinical utility of ramucirumab in advanced gastric cancerBiologics201599310526451083
  • BangYJKimYWYangHKAdjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialLancet2012379981331532122226517
  • SasakoMSakuramotoSKataiHFive-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancerJ Clin Oncol201129334387439322010012
  • SudoKYamadaYAdvancing pharmacological treatment options for advanced gastric cancerExpert Opin Pharmacother201516152293230526359224
  • HanazakiKSodeyamaHMochizukiYPalliative gastrectomy for advanced gastric cancerHepatogastroenterology2001483728528911268986
  • LeeHHHurHKimSHParkARKimWJeonHMOutcomes of modified FOLFOX-6 as first line treatment in patients with advanced gastric cancer in a single institution; retrospective analysisCancer Res Treat2010421182320369047
  • AjaniJARodriguezWBodokyGMulticenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trialJ Clin Oncol20102891547155320159816
  • Malet-MartinoMMartinoRClinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a reviewOncologist20027428832312185293
  • CunninghamDStarlingNRaoSCapecitabine and oxaliplatin for advanced esophagogastric cancerN Engl J Med20083581364618172173
  • SakuramotoSSasakoMYamaguchiTAdjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidineN Engl J Med2007357181810182017978289
  • GiulianiFGebbiaVDe VitaFDocetaxel as salvage therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico Italia Meridionale (G.O.I.M.)Anticancer Res2003235b4219422214666628
  • MuradAMSkareNGVinholesJLagoSPecegoRPhase II multicenter trial of docetaxel, epirubicin, and 5-fluorouracil (DEF) in the treatment of advanced gastric cancer: a novel, safe, and active regimenGastric Cancer2006929910516767365

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.